A 12‐gene signature to distinguish colon cancer patients with better clinical outcome following treatment with 5‐fluorouracil or FOLFIRI

Publisher： John Wiley & Sons Inc

E-ISSN： 2056-4538|1|3|160-172

ISSN： 2056-4538

Source： The Journal Of Pathology: Clinical Research, Vol.1, Iss.3, 2015-06, pp. : 160-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hyperthermic intraperitoneal chemotherapy with mitomycin C and 5fluorouracil in patients at high risk of peritoneal metastasis from colorectal cancer: A preliminary clinical study

By                

Molecular and Clinical Oncology, Vol. 2, Iss. 3, 2014-01 ,pp. : 399-404

Spandidos Publications

Access to resources Recommend Favorite

Expression of the breast cancer resistance protein and 5fluorouracil resistance in clinical breast cancer tissue specimens

By        

Molecular and Clinical Oncology, Vol. 1, Iss. 5, 2013-01 ,pp. : 853-857

Spandidos Publications

Access to resources Recommend Favorite

Phase I study of 5fluorouracil, leucovorin and bevacizumab in combination with radiation therapy in patients with locally advanced rectal cancer

By Inoue   Okigami   Kawamoto   Okugawa   Hiro   Saigusa   Toiyama   Tanaka   Mohri   Kusunoki  

Molecular and Clinical Oncology, Vol. 1, Iss. 3, 2013-01 ,pp. : 511-516

Spandidos Publications

Access to resources Recommend Favorite

Deletion of chromosome 4q predicts outcome in Stage II colon cancer patients

By Brosens R.  

Cellular Oncology, Vol. 34, Iss. 3, 2011-06 ,pp. : 215-223

Springer Publishing Company

Access to resources Recommend Favorite

Docetaxel, cisplatin and 5-fluorouracil adjuvant chemotherapy following three-field lymph node dissection for stage II/III N1, 2 esophageal cancer

By                          

Molecular and Clinical Oncology, Vol. 2, Iss. 5, 2014-01 ,pp. : 719-724

Spandidos Publications

Access to resources Recommend Favorite